372
Participants
Start Date
January 31, 2004
Primary Completion Date
February 28, 2006
Study Completion Date
February 28, 2006
Ambrisentan
St. Vincent's Hospital, Sydney
Mt. Sinai Medical Center, New York
New York Presbyterian Hospital, New York
Northshore University/Long Island Jewish Hospital, Manhasset
Winthrop University Hospital, Mineola
Cardiology PC, Syracuse
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania Hospital, Philadelphia
Johns Hopkins University, Baltimore
University of Virginia Health System, Charlottesville
Virginia Commonwealth University, Richmond
Emory University Hospital, Atlanta
Medical College of Georgia, Augusta
Mt. Sinai Medical Center, Miami
Vanderbilt University Medical Center, Nashville
University Hospitals of Cleveland, Cleveland
Cleveland Clinic Foundation, Cleveland
Lindner Clinical Trial Center, Cincinnati
University of Michigan Medical Center, Ann Arbor
Wayne State University, Detroit
University of Iowa Hospitals and Clinics, Iowa City
Heart Care Associates, Milwaukee
Mayo Clinic, Rochester
Loyola University Medical Center, Chicago
Washington University, St Louis
Ochsner Clinic, New Orleans
St. Paul Hospital, Dallas
Scott & White Hospital, Temple
Baylor College of Medicine, Houston
University of Texas - San Antonio, San Antonio
Myogen, Westminster
University of Colorado Health Sciences Center, Denver
Pulmonary Associates, PA, Phoenix
Arizona Pulmonary Specialists, Phoenix
Brentwood Biomedical Research Institute, Los Angeles
Los Angeles County Harbor-UCLA Medical Center, Torrance
University of California San Diego Medical Center, San Diego
University of California-Davis, Sacramento
Oregon Health Sciences University, Portland
University of Connecticut Health Center, Farmington
Maine Medical Center, Portland
Tufts New England Medical Center, Boston
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Rhode Island Hospital, Providence
Jewish General Hospital, Montreal
Lead Sponsor
Gilead Sciences
INDUSTRY